What this means
This is a planned study that has not started enrolling people yet. It will test whether the treatments change markers of aging and inflammation, but no results exist yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 40 and over
- Where
- 1 site, including California
The science
- Registered title
- Ecosystem Nourishment for Gut Restoration After Fecal Transplantation
- Trial ID
- NCT07826793 ↗
- Phase
- PHASE 2
- Study type
- interventional
- Conditions
- Aging
- What is tested
- Fecal Microbiota Transplant Capsules, Microbiome Rejuvenating Diet, Placebo Fecal Microbiota Transplantation
- Sponsor
- Stanford University
- Ages
- 40 Years to no maximum
- Dates
- First posted Sep 17, 2026 · updated Sep 17, 2026
Registry summary
The purpose of this study is to test whether young-donor fecal microbiome transplantation (FMT) and a fermented, plant-rich high-fiber, microbiome rejuvenating diet (MRD) reduce inflammatory and biological aging markers. Participants (≥40 years) will be randomized (1:1:1:1) for 8 weeks with 4-week follow-up to: (A) diet alone, (B) FMT alone, (C) diet + FMT, or (D) Placebo FMT. We will use rigorously screened young and healthy FMT donors and encapsulated delivery. Outcomes include change from baseline to end of dietary intervention (week 8) in markers of aging and inflammation. Secondary outcomes include defining microbiome engraftment/diversity/function, key metabolites, diet adherence, and quality-of-life.
Sites (1)
- Stanford University, Stanford, California, United States